Metraipolis › archive › dc_3fa71daef6e0

Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications — Europe PMC PMID:40843859

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40843859
DOI
10.3390/medicines12030021
License (as archived)
solo-consultazione
Archived
2026-11-10T12:56:51.813Z
SHA-256 of the archived text
8b23f2feb39da1227f69e2728a00b3d70bfc7af654ed69148ddbdd832e00a967
Stable URL of this page
https://metraipolis.com/documento/dc_3fa71daef6e0

How to cite

Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications — Europe PMC PMID:40843859 — Europe PMC (en), https://europepmc.org/article/MED/40843859 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fa71daef6e0 (Metraipolis archive dc_3fa71daef6e0, sha256 8b23f2feb39da1227f69e2728a00b3d70bfc7af654ed69148ddbdd832e00a967)
BibTeX
@misc{dc3fa71daef6e0,
  title = {Duration of DKA and Insulin Use in People with and Without SGLT2 Inhibitor Medications — Europe PMC PMID:40843859},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40843859},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fa71daef6e0; sha256 8b23f2feb39da1227f69e2728a00b3d70bfc7af654ed69148ddbdd832e00a967},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40843859. Agents can read the archived copy with the MCP tool read_document.